ALHC — Alignment Healthcare, Inc. Stock Price, Chart & AI Report

Negative Aug 26, 2026 • 14:45 UTC GlobeNewswire Inc. • Kaplan Fox & Kilsheimer Llp

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) and Certain of its Officers and Directors for Potential Securities Law Violations

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.

ALHC accounting irregularities whistleblower complaint securities violations financial misstatement Adjusted EBITDA capital expenditures stock decline

Sentiment note

Company is under investigation for accounting fraud involving systematic misclassification of expenses, artificial inflation of financial metrics, and executive compensation manipulation. Stock experienced significant 16.7% decline following whistleblower allegations.

Negative Aug 7, 2026 • 14:45 UTC GlobeNewswire Inc. • Kaplan Fox & Kilsheimer Llp

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026

Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against PROCEPT BioRobotics Corporation for allegedly using undisclosed discount programs that artificially inflated handpiece unit sales and revenues during the Class Period (February 28, 2024 - February 25, 2026). The firm is also pursuing cases against Hub Group, Inc. and investigating potential securities violations at Alignment Healthcare, Inc. Investors with losses are encouraged to contact the firm before respective deadlines.

PRCT HUBG ALHC class action lawsuit securities fraud investor losses handpiece unit sales discount program

Sentiment note

Company is under investigation by Kaplan Fox for potential securities law violations on behalf of investors, suggesting alleged misconduct and investor concerns.

Negative Aug 4, 2026 • 19:44 UTC GlobeNewswire Inc. • Lowey Dannenberg, P.C.

Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Laws

Law firm Lowey Dannenberg is investigating Alignment Healthcare (ALHC) for potential federal securities violations following allegations by a former executive that the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure caused Alignment's stock to fall 16.7% on July 8, 2026.

ALHC securities fraud financial manipulation whistleblower adjusted EBITDA misclassification stock price decline

Sentiment note

Company is under investigation for alleged financial manipulation and accounting fraud involving misclassification of expenses, resulting in significant stock price decline of 16.7% and potential shareholder losses.

Negative Jul 30, 2026 • 13:45 UTC GlobeNewswire Inc. • Portnoy Law Firm

Alignment Healthcare, Inc. Investigated by the Portnoy Law Firm

The Portnoy Law Firm has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) for alleged securities fraud. A former chief transformation officer filed a whistleblower complaint claiming the company misclassified $8-10 million in operational costs as capital expenditures to artificially inflate adjusted EBITDA and boost share price. Following the disclosure on July 8, 2026, Alignment's stock dropped $4.02 per share (16.7%) to $20.03, harming shareholders.

ALHC securities fraud whistleblower complaint accounting distortions adjusted EBITDA capital expenditures class action stock decline

Sentiment note

The company is accused of intentionally misclassifying operational costs as capital expenditures to artificially inflate financial metrics and boost share price. This alleged accounting fraud resulted in a significant 16.7% stock price decline and investor losses.

Negative Jul 29, 2026 • 14:45 UTC GlobeNewswire Inc. • Kaplan Fox & Kilsheimer Llp

Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law Violations

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

ALHC securities violation accounting irregularities whistleblower complaint misclassified expenses Adjusted EBITDA stock decline securities investigation

Sentiment note

Company is under investigation for alleged accounting fraud involving systematic misclassification of operating expenses as capital expenditures, resulting in artificially inflated financial metrics and a 16.7% stock price decline following the whistleblower disclosure.

Negative Jul 28, 2026 • 16:55 UTC GlobeNewswire Inc. • Hagens Berman

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

ALHC financial manipulation accounting irregularities whistleblower EBITDA inflation securities fraud stock decline investor losses

Sentiment note

Company faces serious allegations of deliberate accounting fraud involving misclassification of expenses to inflate financial metrics. Stock experienced a sharp 16.7% single-day decline following whistleblower disclosure, and the company is under formal investigation for potential securities law violations.

Negative Jul 22, 2026 • 14:00 UTC GlobeNewswire Inc. • Kaplan Fox & Kilsheimer Llp

Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding an Investigation of Potential Securities Law Violations

Law firm Kaplan Fox is investigating Alignment Healthcare for alleged accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the whistleblower complaint disclosure.

ALHC accounting irregularities securities violations whistleblower complaint misclassified expenses Adjusted EBITDA stock decline securities litigation

Sentiment note

Company is under investigation for accounting fraud involving systematic misclassification of operating expenses as capital expenditures, resulting in artificially inflated financial results and a 16.7% stock price decline.

Negative Jul 15, 2026 • 19:47 UTC GlobeNewswire Inc. • Hagens Berman

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

ALHC financial manipulation accounting irregularities whistleblower securities fraud EBITDA inflation investor losses class action investigation

Sentiment note

Company faces serious allegations of deliberate financial manipulation and accounting fraud by a former executive. Stock experienced a sharp 16.7% single-day decline following disclosure, and the company is under formal investigation for potential securities law violations and misleading investors about financial health.

Negative Jul 13, 2026 • 18:05 UTC GlobeNewswire Inc. • Block & Leviton Llp

UNCY: Unicycive Therapeutics Investors with Losses Should Contact Block & Leviton About Securities Fraud Investigation

Block & Leviton is investigating Unicycive Therapeutics for potential securities law violations related to false or misleading statements about FDA review of its OLC New Drug Application. The company received a second Complete Response Letter on June 30, 2026, citing manufacturing deficiencies, which led to a stock price decline. Investors who have suffered losses are encouraged to contact the firm.

UNCY ALHC JEF securities fraud FDA approval Complete Response Letter manufacturing deficiencies class action investigation

Sentiment note

Company is under investigation for potential securities law violations by executives, indicating potential fraud concerns.

Negative Jul 9, 2026 • 01:20 UTC GlobeNewswire Inc. • Hagens Berman

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

ALHC financial manipulation accounting irregularities whistleblower securities fraud EBITDA inflation investor losses class action investigation

Sentiment note

Company faces serious allegations of deliberate financial manipulation and accounting fraud by a former executive. Stock experienced a sharp 16.7% decline following disclosure, and the company is under formal investigation for potential securities law violations and misleading investors.

Negative Jul 8, 2026 • 21:47 UTC GlobeNewswire Inc. • Block & Leviton Llp

ALHC ALERT: Block & Leviton Investigating Alignment Healthcare, Inc. For Possible Securities Fraud; Investors Should Contact Block & Leviton to Learn More

Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also investigating Jefferies Financial Group and Unicycive Therapeutics for similar violations.

ALHC JEF UNCY securities fraud whistleblower lawsuit financial manipulation stock price decline investor losses

Sentiment note

Company is under investigation for alleged financial manipulation and securities fraud. Stock experienced a significant 16.72% single-day decline following whistleblower allegations. Investors have suffered losses.

Negative Jul 8, 2026 • 19:42 UTC GlobeNewswire Inc. • Johnson Fistel, Pllp

ALHC Investor Notice: Johnson Fistel Investigates Alignment Healthcare, Inc.

Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking investors who suffered losses.

ALHC securities fraud whistleblower financial manipulation investor losses federal securities laws class action investigation

Sentiment note

The company is under investigation for alleged financial manipulation, stock price manipulation, and potential violations of federal securities laws based on a whistleblower lawsuit from a former executive. These serious allegations of fraud and misconduct warrant a negative sentiment.